$CRNT news
The latest CRNT stock news: headlines, filings, AI summaries and sentiment for $CRNT, updated around the clock.
- Ceragon Networks Reports Q3 2026 Revenue Growth Driven by North American Demand
- Ceragon Networks Reports Q3 Earnings Beat and Updates FY2026 Revenue Guidance
- Ceragon Networks Scheduled to Report Q3 2026 Earnings
- Vertex Raises 2026 Revenue Guidance Amid Portfolio Diversification
- Vertex Pharmaceuticals Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
- Vertex Pharmaceuticals Issues 2026 Revenue Guidance of $13.15B-$13.25B
- Vertex Pharmaceuticals Reports 12% Revenue Growth Driven by Alyftrek Transition
- Amgen vs. Vertex Pharmaceuticals: A Comparison of Revenue Scale and Growth Trajectories
- Ceragon Reports Strong Q2 Revenue Growth Amid Competitive Market Shifts
- Ceragon Networks Reports Q2 Earnings with Strong Revenue Growth in India
- Ceragon Signs Five-Year $70 Million Contract with Long-Term APAC Customer
- Ceragon Networks Secures $3.4M Managed Services Contract with Mexican Mobile Operator
- Ceragon Networks Relies on India to Offset Slow Q1 Performance in 2026
- Ceragon Networks (CRNT) Q1 2026 Earnings Call Transcript
- Ceragon Networks Reports Q1 Revenue and Guidance for 2026